Aardvark Therapeutics, Inc. Common Stock
Market Cap
$119.12M
P/E Ratio
-1.86
EPS
$-2.93
Dividend Yield
0.00%
52-Week Range
$3.35 — $17.94
Volume
82.26K
Avg Volume
281.33K
Beta
5.34
Get alerted when AARD hits your target price.
Free — enter your email to get started
P/E (TTM)
-1.86
Forward P/E
—
PEG Ratio
0.34
P/S (TTM)
0.00
P/B (TTM)
0.84
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.45%
ROA (TTM)
-0.49%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
10.61
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.41%
EPS Growth (5Y)
-0.41%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-3.45
EPS Est (Next Year)
$-3.56
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$5.04
Price Target Range
Consensus Target: $29.33(437.2% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
0
Outstanding Shares
21.82M
Float
11.22M
Free Float %
51.41%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2025-02-13
Employees
22
CEO
Tien-Li Lee
Index Membership
—
Website
https://aardvarktherapeutics.com
Aardvark Therapeutics, Inc. Common Stock (AARD) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $119.12M, a P/E ratio of -1.86, AARD is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AARD against other stocks using dozens of fundamental and technical filters.
Aardvark Therapeutics, Inc. Common Stock (AARD) has a trailing twelve-month (TTM) P/E ratio of -1.86. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Aardvark Therapeutics, Inc. Common Stock (AARD) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Aardvark Therapeutics, Inc. Common Stock (AARD) has a market capitalization of $119.12 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.